Back

Predictive value of cardiac 18F-fluorodeoxyglucose positron emission tomography for fatal ventricular arrhythmic events in patients with cardiac sarcoidosis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Positron emission tomography innovations in diagnosis and prognosis Inflammation, Infection, and Infiltrative Cardiovascular Disorders ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kouki Takeuchi

Tohoku University Hospital, Sendai (Japan)

6 More presentations in this session

Presentation thumbnail
Usefulness of visual classification for cardiac pathophysiology using count-washout rate map in iodine-123-beta-methyl-P-iodophenyl-pentadecanoic acid scintigraphy
Doctor R. Ono (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Heparin does not improve myocardial glucose metabolism suppression in patients with low betahydroxybutyrate level
Doctor S. Hartikainen (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Assessment of impact of left ventricular flow state on myocardial blood flow using positron emission tomography and echocardiography
Doctor M. Pu (New York, US) Doctor B. Chen (Bronx, US)
Abstract Slides Video
Presentation thumbnail
18F-FDG PET/CT in the diagnosis of infective endocarditis
Miss L. Salminen (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Hypoperfused myocardium and systolic function in patients with AMI undergoing complete revascularization
Doctor J. Si (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Positron emission tomography innovations in diagnosis and prognosis

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of 18F-fluorodeoxyglucose positron emission tomography and 67gallium scintigraphy in cardiac sarcoidosis.
thumbnail
Congress Presentation
Multimodality imaging to improve detection and prognostication of right ventricular involvement in cardiac sarcoidosis
thumbnail
Congress Presentation
The role of 18fluorine-fluorodeoxyglucose positron emission tomography in the diagnosis, follow-up, and regulation of treatment in patients with cardiac sarcoidosis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources